| OTCM Exchange | United States Country |
The fund is designed to offer investors exposure to the NASDAQ 100 Index®, which comprises 100 of the largest non-financial domestic and international companies listed on the Nasdaq Stock Market. By aiming to maintain at least 80% of its assets in the stocks included in the NASDAQ 100 Index® according to their market capitalization weightings, the fund seeks to mirror the performance of the index. This investment strategy positions the fund primarily for investors seeking to replicate the performance of the NASDAQ 100 Index®, involving substantial investments in technology and biotech sectors, among others, given the composition of the index. As a non-diversified fund, it concentrates its investments more heavily in fewer securities, making it more susceptible to risks associated with individual companies.
The primary offering of this investment vehicle is closely tied to the performance and composition of the NASDAQ 100 Index®. Below is a breakdown of its main product and associated characteristics:
This fund primarily invests in the stocks of the NASDAQ 100 Index®, following the weightings of these companies in the index. By targeting at least 80% of its assets towards these investments, the fund seeks to closely track the performance of the NASDAQ 100. This index is known for its heavy concentration in technology and innovation-driven companies, making the fund an attractive option for investors seeking exposure to some of the largest and most influential technological and biotech companies in the global market. The investments span across both domestic and international companies, providing a diversified geographical exposure within the tech-centric scope of the NASDAQ 100.